HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

maftivimab

Also Known As:

REGN-3479; REGN3479; maftivimab-ebgn

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Alter, Galit: 1 article (01/2021)
2.	Bombardi, Robin G: 1 article (01/2021)
3.	Bonissone, Stefano R: 1 article (01/2021)
4.	Bukreyev, Alexander: 1 article (01/2021)
5.	Castellana, Natalie: 1 article (01/2021)
6.	Chen, Elaine C: 1 article (01/2021)
7.	Crowe, James E: 1 article (01/2021)
8.	Davidson, Edgar: 1 article (01/2021)
9.	Doranz, Benjamin J: 1 article (01/2021)
10.	Gilchuk, Pavlo: 1 article (01/2021)

Related Diseases

1.

Ebola Hemorrhagic Fever

01/01/2021 - "The largest Ebola virus disease (EVD) epidemic to date in 2013-2016 in West Africa highlighted the urgent need for countermeasures, leading to the development and FDA approval of the Ebola virus vaccine rVSV-ZEBOV (Ervebo®) in 2020 and two monoclonal antibody (mAb)-based therapeutics (Inmazeb® [atoltivimab, maftivimab, and odesivimab-ebgn] and Ebanga® (ansuvimab-zykl) in 2020. "

Related Drugs and Biologics

1.	Ebola Vaccines
2.	Monoclonal Antibodies
3.	odesivimab
4.	atoltivimab
5.	ansuvimab

Related Therapies and Procedures

1.	Therapeutics